Logo image of SCX

STARRETT (L.S.) CO -CL A (SCX) Stock Fundamental Analysis

NYSE:SCX - New York Stock Exchange, Inc. - US8556681091 - Common Stock - Currency: USD

16.18  +0.01 (+0.06%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SCX. SCX was compared to 128 industry peers in the Machinery industry. While SCX has a great health rating, its profitability is only average at the moment. SCX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year SCX was profitable.
In the past year SCX had a positive cash flow from operations.
SCX had positive earnings in 4 of the past 5 years.
Of the past 5 years SCX 4 years had a positive operating cash flow.
SCX Yearly Net Income VS EBIT VS OCF VS FCFSCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

With an excellent Return On Assets value of 10.38%, SCX belongs to the best of the industry, outperforming 83.08% of the companies in the same industry.
SCX has a better Return On Equity (14.81%) than 70.00% of its industry peers.
SCX has a Return On Invested Capital (7.46%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SCX is in line with the industry average of 10.71%.
Industry RankSector Rank
ROA 10.38%
ROE 14.81%
ROIC 7.46%
ROA(3y)9.28%
ROA(5y)3.69%
ROE(3y)16.98%
ROE(5y)2.17%
ROIC(3y)10.36%
ROIC(5y)7.65%
SCX Yearly ROA, ROE, ROICSCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40

1.3 Margins

The Profit Margin of SCX (7.72%) is better than 61.54% of its industry peers.
SCX's Operating Margin of 5.64% is in line compared to the rest of the industry. SCX outperforms 41.54% of its industry peers.
In the last couple of years the Operating Margin of SCX has grown nicely.
SCX has a Gross Margin of 31.48%. This is comparable to the rest of the industry: SCX outperforms 57.69% of its industry peers.
In the last couple of years the Gross Margin of SCX has remained more or less at the same level.
Industry RankSector Rank
OM 5.64%
PM (TTM) 7.72%
GM 31.48%
OM growth 3Y77.51%
OM growth 5Y28.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y0.19%
SCX Yearly Profit, Operating, Gross MarginsSCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SCX is creating some value.
SCX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SCX has more shares outstanding
Compared to 1 year ago, SCX has an improved debt to assets ratio.
SCX Yearly Shares OutstandingSCX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
SCX Yearly Total Debt VS Total AssetsSCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 4.24 indicates that SCX is not in any danger for bankruptcy at the moment.
The Altman-Z score of SCX (4.24) is better than 71.54% of its industry peers.
SCX has a debt to FCF ratio of 0.50. This is a very positive value and a sign of high solvency as it would only need 0.50 years to pay back of all of its debts.
SCX has a Debt to FCF ratio of 0.50. This is amongst the best in the industry. SCX outperforms 91.54% of its industry peers.
SCX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.02, SCX belongs to the top of the industry, outperforming 82.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.5
Altman-Z 4.24
ROIC/WACC0.81
WACC9.21%
SCX Yearly LT Debt VS Equity VS FCFSCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

SCX has a Current Ratio of 3.11. This indicates that SCX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.11, SCX is in the better half of the industry, outperforming 76.15% of the companies in the same industry.
SCX has a Quick Ratio of 1.42. This is a normal value and indicates that SCX is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.42, SCX is doing good in the industry, outperforming 63.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.11
Quick Ratio 1.42
SCX Yearly Current Assets VS Current LiabilitesSCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.20% over the past year.
The Revenue has decreased by -2.50% in the past year.
The Revenue has been growing slightly by 3.44% on average over the past years.
EPS 1Y (TTM)33.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.51%
Revenue 1Y (TTM)-2.5%
Revenue growth 3Y8.33%
Revenue growth 5Y3.44%
Sales Q2Q%-7.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SCX Yearly Revenue VS EstimatesSCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.32, the valuation of SCX can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of SCX indicates a rather cheap valuation: SCX is cheaper than 95.38% of the companies listed in the same industry.
SCX is valuated cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.32
Fwd PE N/A
SCX Price Earnings VS Forward Price EarningsSCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SCX is valued cheaply inside the industry as 91.54% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, SCX is valued cheaper than 96.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.15
EV/EBITDA 5.98
SCX Per share dataSCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SCX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STARRETT (L.S.) CO -CL A

NYSE:SCX (5/22/2024, 8:04:00 PM)

16.18

+0.01 (+0.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-06 2024-05-06/amc
Earnings (Next)09-13 2024-09-13/amc
Inst Owners0.39%
Inst Owner Change0%
Ins Owners1.65%
Ins Owner Change0%
Market Cap121.51M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.32
Fwd PE N/A
P/S 0.48
P/FCF 8.15
P/OCF 4.38
P/B 0.93
P/tB 0.97
EV/EBITDA 5.98
EPS(TTM)2.56
EY15.82%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.99
FCFY12.27%
OCF(TTM)3.69
OCFY22.81%
SpS33.51
BVpS17.46
TBVpS16.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.38%
ROE 14.81%
ROCE 9.41%
ROIC 7.46%
ROICexc 7.75%
ROICexgc 8.08%
OM 5.64%
PM (TTM) 7.72%
GM 31.48%
FCFM 5.93%
ROA(3y)9.28%
ROA(5y)3.69%
ROE(3y)16.98%
ROE(5y)2.17%
ROIC(3y)10.36%
ROIC(5y)7.65%
ROICexc(3y)11.22%
ROICexc(5y)8.32%
ROICexgc(3y)11.72%
ROICexgc(5y)8.76%
ROCE(3y)13.07%
ROCE(5y)9.65%
ROICexcg growth 3Y86.71%
ROICexcg growth 5Y30.58%
ROICexc growth 3Y87.08%
ROICexc growth 5Y32.25%
OM growth 3Y77.51%
OM growth 5Y28.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y0.19%
F-Score6
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.5
Debt/EBITDA 0.15
Cap/Depr 199.08%
Cap/Sales 5.09%
Interest Coverage 12.47
Cash Conversion 134.39%
Profit Quality 76.76%
Current Ratio 3.11
Quick Ratio 1.42
Altman-Z 4.24
F-Score6
WACC9.21%
ROIC/WACC0.81
Cap/Depr(3y)116.97%
Cap/Depr(5y)119.33%
Cap/Sales(3y)3.09%
Cap/Sales(5y)3.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.51%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.5%
Revenue growth 3Y8.33%
Revenue growth 5Y3.44%
Sales Q2Q%-7.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-39.78%
EBIT growth 3Y92.3%
EBIT growth 5Y32.51%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y256.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1255.04%
OCF growth 3YN/A
OCF growth 5Y43.93%